• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：哥伦比亚人群中针对Mu和Gamma SARS-CoV-2变体的交叉反应性体液和CD4 T细胞反应。

Corrigendum: Cross-reactive humoral and CD4 T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population.

作者信息

Martel Fabiola, Cuervo-Rojas Juliana, Ángel Juana, Ariza Beatriz, González John Mario, Ramírez-Santana Carolina, Acosta-Ampudia Yeny, Murcia-Soriano Luisa, Montoya Norma, Cardozo-Romero Claudia Cecilia, Valderrama-Beltrán Sandra Liliana, Cepeda Magda, Castellanos Julio César, Gómez-Restrepo Carlos, Perdomo-Celis Federico, Gazquez Andreu, Dickson Alexandria, Brien James D, Mateus José, Grifoni Alba, Sette Alessandro, Weiskopf Daniela, Franco Manuel A

机构信息

Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.

Department of Clinical Epidemiology and Biostatistics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.

出版信息

Front Immunol. 2023 Aug 16;14:1274753. doi: 10.3389/fimmu.2023.1274753. eCollection 2023.

DOI:10.3389/fimmu.2023.1274753
PMID:37662943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10469294/
Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1241038.].

摘要

[本文更正了文章DOI：10.3389/fimmu.2023.1241038。]

相似文献

1
Corrigendum: Cross-reactive humoral and CD4 T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population.勘误：哥伦比亚人群中针对Mu和Gamma SARS-CoV-2变体的交叉反应性体液和CD4 T细胞反应。
Front Immunol. 2023 Aug 16;14:1274753. doi: 10.3389/fimmu.2023.1274753. eCollection 2023.
2
Longitudinal Follow-Up of the Immunity to SARS-CoV-2 in Health Care Workers in Argentina: Persistence of Humoral Response and Neutralizing Capacity after Sputnik V Vaccination.阿根廷卫生保健工作者对 SARS-CoV-2 免疫力的纵向随访：接种卫星 V 疫苗后体液反应和中和能力的持久性。
mSphere. 2023 Jun 22;8(3):e0066222. doi: 10.1128/msphere.00662-22. Epub 2023 Apr 18.
3
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.COVID-19 患者在突破感染 SARS-CoV-2 变异株 Delta、Omicron-BA.1 和 Omicron-BA.5 期间的免疫反应。
Front Immunol. 2023 Jul 13;14:1150667. doi: 10.3389/fimmu.2023.1150667. eCollection 2023.
4
Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern.第三剂 SARS-CoV-2 疫苗接种和突破性感染增强了针对关注变种的体液和细胞免疫。
Front Immunol. 2023 Mar 22;14:1120010. doi: 10.3389/fimmu.2023.1120010. eCollection 2023.
5
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.突破性感染后回忆性免疫的程度和时间由 SARS-CoV-2 变体决定。
Immunity. 2022 Jul 12;55(7):1316-1326.e4. doi: 10.1016/j.immuni.2022.05.018. Epub 2022 May 27.
6
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.奥密克戎 BA.1 特异性 T 细胞应答在香港接种科兴或辉瑞疫苗的成年人中的观察性队列研究。
Lancet Microbe. 2023 Jun;4(6):e418-e430. doi: 10.1016/S2666-5247(23)00006-X. Epub 2023 Apr 20.
7
Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity.勘误：感染SARS-CoV-2的奥密克戎和德尔塔变体所导致的突破性感染会使疫苗诱导的免疫力产生类似的重新激活。
Front Immunol. 2023 Jul 12;14:1249100. doi: 10.3389/fimmu.2023.1249100. eCollection 2023.
8
Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine.病例报告：BNT162b2 疫苗接种后两次 COVID-19 突破感染的体液和细胞免疫演变。
Front Immunol. 2022 Feb 23;13:790212. doi: 10.3389/fimmu.2022.790212. eCollection 2022.
9
Neutralizing Antibody Responses against Five SARS-CoV-2 Variants and T Lymphocyte Change after Vaccine Breakthrough Infections from the SARS-CoV-2 Omicron BA.1 Variant in Tianjin, China: A Prospective Study.中国天津地区针对 SARS-CoV-2 奥密克戎 BA.1 变异株疫苗突破性感染后五种 SARS-CoV-2 变异株的中和抗体反应和 T 淋巴细胞变化的前瞻性研究。
Biomed Environ Sci. 2023 Jul 20;36(7):614-624. doi: 10.3967/bes2023.047.
10
Timing of SARS-CoV-2 Vaccination Matters in People With Multiple Sclerosis on Pulsed Anti-CD20 Treatment.SARS-CoV-2 疫苗接种时机对接受脉冲式抗 CD20 治疗的多发性硬化症患者很重要。
Neurol Neuroimmunol Neuroinflamm. 2022 Oct 12;9(6). doi: 10.1212/NXI.0000000000200031. Print 2022 Nov.